A Study of Olomorasib (LY3537982) in Participants With Hepatic Impairment and Healthy Participants

Clinical trial NCT06719128 · COMPLETED

Trial details

NCT number: NCT06719128
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Insufficiency Healthy

Start date: 2024-12-06
Primary completion: 2025-08-25
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.